Facebook
Twitter
LinkedIn
ForwardMayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium 2023
This course offers Live (in-person) and Livestream (virtual) attendance options
Course Directors: Tanios S. Bekaii-Saab, M.D., Mitesh J. Borad, M.D., Sean P. Cleary, M.D., and G. Dan Duda, D.M.D., Ph.D.
November 10 - 11, 2023 - Encore at Wynn Las Vegas - Las Vegas, Nevada
 | In collaboration with the International Association of Surgeons, Gastroenterologists and Oncologists (IASGO) |
The 2023 Mayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium will provide a multidisciplinary overview on the importance of early diagnosis and treatment considerations, including surgery, radiation, loco-regional approaches, and systemic therapies. Nationally and internationally renowned faculty will offer state-of-the-art updates on current treatment options for patients with hepato-pancreatico-biliary cancers. This timely education will be delivered through case-based discussions, interactive Q&A, and didactic presentations. Target audience for this activity includes physicians and allied health professionals.
| Registration Fee | |
|---|---|
| $610 |
| $485 |
Target Audience
This course is intended for surgeons, gastroenterologists, medical and radiation oncologists, laboratory scientists, and allied health professionals in the following specialties: medical oncology, hematology, gastroenterology, radiation oncology, surgical oncology, pathology, radiology, and laboratory research science.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe innovative options for patients with pancreas, liver and biliary cancers with limited oligometastatic disease.
- Identify current and emerging strategies for early diagnosis of liver cancer.
- Identify patients suitable for a liver transplantation, surgical resection, radiation therapy, or other loco-regional approaches.
- Integrate novel molecularly-targeted strategies in clinical trial participation.
- Recognize the appropriate regimen for first and second line therapy in treating advanced pancreatic cancer, liver and biliary cancer.
- Describe the latest state of the science in pancreatic cancer, liver and biliary cancer.
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
Click here to view Program Schedule on mobile
A limited block of guest rooms has been reserved for attendees at a special group rate. A daily resort fee of $45.00 plus 13.38% tax will be added to each guest room account. The resort fee and tax are both subject to change.
Room | Weekday Rate (Sun-Thur) | Weekend Rate (Fri-Sat) |
Resort Suite Guestroom | $ 229.00 | $ 369.00 |
Resort Suite Two Queens | $ 279.00 | $ 419.00 |
Please note that there is a charge of $50.00 per room per night for double queen accommodations at Encore for weekday; and $70.00 per room per night for weekends.
A charge of $50 per night will be added for each guest over double occupancy. Group rates will be subject to the prevailing room tax, which is currently 13.38%. Subject to change.
Online Reservation Link
Make your reservation before the block fills or the cut-off date of October 10, 2023, 5 p.m. (PST). Rates are based on group rate availability. A charge of $50 per night will be added for each guest over double occupancy.
Cancellation Policy
Deposit fully refundable provided reservation is cancelled at least 72 hours prior to arrival. Reservations cancelled with-in 72 hours of arrival are subject to a one-night cancellation penalty.
All travel and lodging expenses are the sole responsibility of the individual registrant.
Course Directors
Tanios S. Bekaii-Saab, M.D.
Professor of Medicine, Mayo Clinic College of Medicine and Science
Mayo Clinic
Phoenix, Arizona
Mitesh J. Borad, M.D.
Professor of Medicine, Mayo Clinic College of Medicine and Science
Mayo Clinic
Phoenix, Arizona
Sean P. Cleary, M.D.
Professor of Surgery, Mayo Clinic College of Medicine and Science
Division Chair, Hepatobiliary/Pancreatic Surgery
Mayo Clinic
Rochester, Minnesota
G. Dan Duda, DMD, PhD, FAIMBE, FAAAS
Director of Translational Research in GI Radiation Oncology,
Massachusetts General Hospital
Investigator, Edwin L. Steele Laboratories for Tumor Biology,
Massachusetts General Hospital Research Institute
Associate Professor of Tumor Biology, Harvard Medical School
Massachusetts General Hospital
Boston, Massachusetts
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 8.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals:
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 8.75 AMA PRA Category 1 Credit™
- 8.75 Attendance
For information regarding exhibit opportunities, please reach out to Kristy Badder.
Cancellation and Refund Policy
View Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.